Authors:
Address: Department of Medical Pathophysiology, University La Sapienza, Rome, Italy. g.barbaro@tin.it
Journal:

Publication:

abstract

Highly active antiretroviral therapy (HAART) significantly changed the prevalence of the cardiovascular manifestations of Human immunodeficiency virus (HIV)/AIDS. In developed countries, a 30 per cent reduction in the prevalence of cardiomyopathy and pericardial effusion was observed, possibly related to a reduction of opportunistic infections and myocarditis. In developing countries, however, where the availability of HAART is limited, and the pathogenic impact of nutritional factors is significant, a 32 per cent increase was seen in the prevalence of cardiomyopathy and related high mortality rate from congestive heart failure. Also, some HAART regimens in developed countries, especially those including protease inhibitors, may cause, in a high proportion of HIV-infected patients, a lipodystrophy syndrome that is associated with an increased risk of cardiovascular events related to a process of accelerated atherosclerosis. Careful cardiac screening is warranted for patients who are being evaluated for, or who are receiving HAART regimens, particularly for those with known underlying cardiovascular risk factors, according to the most recent clinical guidelines.

Related Articles
Heart and HAART: Two sides of the coin for HIV-associated cardiology issues.
World J Cardiol. 2010
Heart and HAART: Two sides of the coin for HIV-associated cardiology issues.
Barbaro G. World J Cardiol. 2010 Mar 26; 2(3):53-7.
Review Cardiovascular complications in the acquired immunodeficiency syndrome.
Rev Assoc Med Bras. 2009
Review Cardiovascular complications in the acquired immunodeficiency syndrome.
Barbaro G, Silva EF. Rev Assoc Med Bras. 2009 Sep-Oct; 55(5):621-30.
Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.
Curr Drug Targets Cardiovasc H...
Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.
Barbaro G. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Aug; 5(4):337-43.
Review Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.
Chemotherapy. 2006
Review Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.
Barbaro G, Barbarini G. Chemotherapy. 2006; 52(4):161-5. Epub 2006 May 2.
Review Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Verh K Acad Geneeskd Belg. 2001
Review Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K. Verh K Acad Geneeskd Belg. 2001; 63(5):447-73.
The evolving Indian AIDS epidemic: hope & challenges of the fourth decade.
Indian J Med Res. 2011
The evolving Indian AIDS epidemic: hope & challenges of the fourth decade.
Mayer K. Indian J Med Res. 2011 Dec; 134(6):739-41.

To top • Home

---

Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer • webmaster